Scion Pharmaceuticals, Inc.

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 50.0

Forward Citations = 20

Loading Chart...

11 inventors (with patents filed for the assignee):

Graham J Durant (2 out of 29 patents)

Diane Lipscombe (1 out of 4 patents)

Seetharamaiyer Padmanabhan (1 out of 16 patents)

4. Stephanie Schorge (1 out of 3 patents)

5. Ted Ebendal (1 out of 3 patents)

6. Michael Maillard (1 out of 6 patents)

7. David Berlove (1 out of 9 patents)

8. Michael Jarpe (1 out of 1 patent)

9. Mark Andrew Marchionni (1 out of 24 patents)

10. N Laxma Reddy (1 out of 24 patents)

11. Sharad S Magar (1 out of 18 patents)

4 patents: Sort by Forward Citations

1. 8038995 - Human N-type calcium channel isoform and uses thereof (2011-10-18),

2. 7041702 - Pharmaceutically active compounds and methods of use (2006-05-09),

3. 6872698 - Methods for treating neurological injuries and disorders (2005-03-29),

4. 6514990 - Pharmaceutically active compounds and methods of use (2003-02-04),

Company Overview

Scion Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing novel treatments for rare and orphan diseases. With a team of experienced researchers and a strong pipeline of drug candidates, we are dedicated to advancing medical science and improving the lives of patients worldwide. Our innovative approach to drug discovery and development has led to promising results in preclinical studies, and we are committed to bringing these potential therapies to market through rigorous clinical trials and regulatory approval processes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#14 in Medford, MA

#3,314 in Massachusetts

#60,671 in US

Medford, MA, United States of America